Cargando…
Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
We share our experience of a patient with pulmonary alveolar proteinosis who was refractory to plasmapheresis and rituximab despite a significant reduction in the offending antibody. He presented with shortness of breath, fevers, chills, and sweats for 4 months. He was diagnosed with autoimmune PAP...
Autores principales: | Keske, Aysenur, Destrampe, Eric M., Barksdale, Byron, Rose, William N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818429/ https://www.ncbi.nlm.nih.gov/pubmed/35140990 http://dx.doi.org/10.1155/2022/2104270 |
Ejemplares similares
-
Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
por: Piccoli, Luca, et al.
Publicado: (2015) -
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm
por: Imoto, Naoto, et al.
Publicado: (2017) -
Proteinosis alveolar. Remisión completa tras tratamiento con GM-CSF inhalado
por: López Monzoni, Sonia, et al.
Publicado: (2022) -
Utility of anti-GM-CSF antibodies in the diagnosis of pulmonary alveolar proteinosis: a case report
por: Sierra-Rivera, Antonio, et al.
Publicado: (2023) -
Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis
por: Salvator, Hélène, et al.
Publicado: (2022)